← SynDRA
LERISETRON
SynDRA canonical compound SYN0002704 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | HTR3A |
|---|
| Mechanism of action | Serotonin receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- Serotonin receptor antagonist
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- HDAC6
- MBD4
- MPG
- MUTYH
- NEIL1
- NEIL2
- NTHL1
- OGG1
- TDG
- UNG
Cross-references
Synonyms
- Lerisetron[inn]
- 1-benzyl-2-piperazin-1-ylbenzimidazole
- Lerisetron [INN]
- 1-Benzyl-2-(piperazin-1-yl)-1H-benzo[d]imidazole
- Q36R82SXRG
- CHEMBL56900
- 1-Benzyl-2-(1-piperazinyl)benzimidazole
- 1-Benzyl-2-piperazin-1-yl-1H-benzoimidazole
- 1-benzyl-2-(piperazin-1-yl)-1H-1,3-benzodiazole
- UNII-Q36R82SXRG
- LERISETRON [WHO-DD]
- SCHEMBL141124
- ZINC7943
- DTXSID90162368
- BCP33052
- BDBM50103072
- s2644
- AKOS015957715
- DB12964
- 1-benzyl-2-piperazin-1-ylbenzimidazole.
- HY-105090
- trans-cyclohexane-1,3-diamine?hydrochloride
- CS-0024958
- L-175
- 1-benzyl-2-(piperazin-1-yl)-1H-benzimidazole
- EN300-242559
- Q6528811
- Z2049693817
- lerisetronum
- RefChem:152881
- DTXCID5084859
- F-0930-RS2
- 1-Phenyl-Methyl-2-Piperazinyl-1H-Benzimidazole Hydrochloride
- orb1298932
- SCHEMBL30669539
- PWWDCRQZITYKDV-UHFFFAOYSA-N
- EX-A7543
- TFA25798
Look up LERISETRON in the interactive SynDRA portal →